| Dr Wilton A Guillory Iii, DC | |
|
1226 Windsor Pl, Alexandria, LA 71303-2748 | |
| (318) 487-0960 | |
| (318) 487-2002 |
| Full Name | Dr Wilton A Guillory Iii |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 18 Years |
| Location | 1226 Windsor Pl, Alexandria, Louisiana |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669402160 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 1409 (Louisiana) | Primary |
| Provider Name | Wilton A Guillory Iii, Dc, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1831268333 PECOS PAC ID: 5193724128 Enrollment ID: O20061220000212 |
News Archive
Current research suggests that lowering cholesterol may block the growth of prostate tumors.
OPKO Health, Inc. today announced that it has entered into a collaboration agreement with Bristol-Myers Squibb Company relating to OPKO's new diagnostic test technology. OPKO's simple blood tests are being developed, based on its proprietary platform technology, to identify biomarkers for a wide variety of diseases including neurodegenerative disorders and various malignancies.
New research by scientists at Australia's Macquarie University will investigate antibiotic resistance genes in humans in an effort to combat worldwide death rates due to infectious diseases and reduce the growing burden on our health system by decreasing patients' length of stay.
Ventas, Inc. ("Ventas" or the "Company") announced today that management will make a presentation regarding the Company at the NAREIT REITWeek 2014 Conference in New York, New York on Wednesday, June 4, 2014, at 3:45 p.m. Eastern Time.
Titan Pharmaceuticals, Inc. today announced the initiation of a randomized, placebo and active controlled, multi-center Phase 3 clinical study of Probuphine in the treatment of opioid addiction. This confirmatory Phase 3 study will be conducted at approximately 23 sites in the United States and randomize approximately 250 patients into three arms: Probuphine (100 patients), Suboxone® (100 patients) and placebo (50 patients).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Wilton A Guillory Iii, DC 1226 Windsor Pl, Alexandria, LA 71303-2748 Ph: (318) 487-0960 | Dr Wilton A Guillory Iii, DC 1226 Windsor Pl, Alexandria, LA 71303-2748 Ph: (318) 487-0960 |
News Archive
Current research suggests that lowering cholesterol may block the growth of prostate tumors.
OPKO Health, Inc. today announced that it has entered into a collaboration agreement with Bristol-Myers Squibb Company relating to OPKO's new diagnostic test technology. OPKO's simple blood tests are being developed, based on its proprietary platform technology, to identify biomarkers for a wide variety of diseases including neurodegenerative disorders and various malignancies.
New research by scientists at Australia's Macquarie University will investigate antibiotic resistance genes in humans in an effort to combat worldwide death rates due to infectious diseases and reduce the growing burden on our health system by decreasing patients' length of stay.
Ventas, Inc. ("Ventas" or the "Company") announced today that management will make a presentation regarding the Company at the NAREIT REITWeek 2014 Conference in New York, New York on Wednesday, June 4, 2014, at 3:45 p.m. Eastern Time.
Titan Pharmaceuticals, Inc. today announced the initiation of a randomized, placebo and active controlled, multi-center Phase 3 clinical study of Probuphine in the treatment of opioid addiction. This confirmatory Phase 3 study will be conducted at approximately 23 sites in the United States and randomize approximately 250 patients into three arms: Probuphine (100 patients), Suboxone® (100 patients) and placebo (50 patients).
› Verified 5 days ago
Dr. Kelly B. Faircloth, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 11 Heyman Ln, Alexandria, LA 71303 Phone: 318-448-8462 Fax: 318-448-8486 | |
Mr. Dean Richard Lindsay, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1408 Peterman Dr, Alexandria, LA 71301 Phone: 318-487-0422 Fax: 318-473-9126 | |
Dr. Peyton John Curtis Nelson, Chiropractor Medicare: Medicare Enrolled Practice Location: 2595 N Macarthur Dr, Alexandria, LA 71303 Phone: 318-443-1313 Fax: 318-443-1366 | |
Alexandria Spine & Rehab Center Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 1133 Macarthur Dr, Ste. B, Alexandria, LA 71303 Phone: 318-561-6250 Fax: 318-561-6252 | |
Charles Rud Whittington, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1427 Peterman Dr, Alexandria, LA 71301 Phone: 318-445-8000 Fax: 318-445-8000 | |
Dr. Bradley F Kirzner, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1133 Macarthur Dr, Suite B, Alexandria, LA 71303 Phone: 318-561-6250 Fax: 318-561-6252 | |
Dr. Meril Joseph Dufrene, Jr., D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3327 Jackson St, Suite F, Alexandria, LA 71301 Phone: 318-445-2513 Fax: 318-445-2910 |